Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Mavroukakis

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Journal of Oncology Nursing|March 22, 2002
Clinical pathways for managing patients receiving interleukin 2S A Mavroukakis, P M Muehlbauer, R L White, et al.
Dimensions of Critical Care Nursing : DCCN|July 1, 1997
Merging a PICU and MICU: a debateD C Dominguez, D L Clarke, S A Mavroukakis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2G A Ohnmacht, G Q Phan, S A Mavroukakis, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Journal of Oncology Nursing|March 22, 2002
Clinical pathways for managing patients receiving interleukin 2S A Mavroukakis, P M Muehlbauer, R L White, et al.
Dimensions of Critical Care Nursing : DCCN|July 1, 1997
Merging a PICU and MICU: a debateD C Dominguez, D L Clarke, S A Mavroukakis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 2001
A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2G A Ohnmacht, G Q Phan, S A Mavroukakis, et al.
Pageof 1